Alinity i Processing Module

  • Model / Serial
    Catalog Number: 03R65-01 Serial Number: Ai01105 Ai01025 Ai01081 Ai01103 Ai01152 Ai01027 Ai01082 Ai01104 Ai01156 Ai01032 Ai01083 Ai01115 Ai01157 Ai01036 Ai01084 Ai01120 Ai01158 Ai01055 Ai01086 Ai01121 Ai01159 Ai01056 Ai01087 Ai01122 Ai01160 Ai01057 Ai01088 Ai01123 Ai01161 Ai01064 Ai01089 Ai01124 Ai01162 Ai01065 Ai01090 Ai01125 Ai01164 Ai01066 Ai01091 Ai01126 Ai01165 Ai01067 Ai01092 Ai01127 Ai01166 Ai01068 Ai01093 Ai01129 Ai01169 Ai01070 Ai01094 Ai01130 Ai01170 Ai01071 Ai01095 Ai01132 Ai01171 Ai01072 Ai01096 Ai01134 Ai01172 Ai01073 Ai01098 Ai01135 Ai01176 Ai01074 Ai01099 Ai01136 Ai01182 Ai01076 Ai01100 Ai01137 Ai01194 Ai01077 Ai01101 Ai01153 Ai01015 Ai01079
  • Product Description
    Diagnostic medical devices in vitro
  • Manufacturer
  • 1 Event

Manufacturer

  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    MHSIDCCCDMIS

16 devices with a similar name

Learn more about the data here

  • Model / Serial
    ALINITY CI-SERIES MODULE, all serials.
  • Product Description
    It is a fully automated immunoassay system that allows random and continuous access, as well as priority processing and automatic re-analysis using chemoluminescent micro-particle immunoassay technology. CMIA technology is used to determine the presence of antigens, antibodies and analytes in samples. The scalable design of the ALINITY I allows one or more sample processing modules, in multiple configurations, with a system control module to physically join together to form a single workstation.
  • Manufacturer
  • Model / Serial
  • Manufacturer
    N/A
11 more